Nevro Corp (NYSE:NVRO)
11.62 USD
-0.890 7.114%Previous Close (in USD) | 12.51 |
---|---|
Change | -0.890 7.114% |
52 W H/L (in USD) | 41.705/13.980 |
EBITDA (in USD) | -100.422M |
PE Ratio | -- |
Volume | 345069 |
Diluted Eps TTM | -2.87 |
Total Assets (in USD) | 602.408M |
---|---|
Total Liabilities (in USD) | 278.532M |
Revenue TTM (in USD) | 422.842M |
Cash (in USD) | 120.373M |
Market Cap (in USD) | 778.418 M |
Revenue Per Share TTM | 11.818 |
Gross Profit TTM (in USD) | 276.367M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Nevro Corp
Employees: 1087
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Mr. D. Keith Grossman | Chairman, CEO & Pres | 1960 |
2. | Mr. Roderick H. MacLeod | Chief Financial Officer | 1967 |
3. | Mr. Kashif Rashid | Gen. Counsel, Corp. Sec. & Chief Compliance Officer | 1974 |
4. | Ms. Niamh Louise Pellegrini | Chief Commercial Officer | 1967 |
5. | Mr. Patrick Schmitz | VP of Operations | 1960 |
6. | Mr. Richard B. Carter | Chief Accounting Officer | 1971 |
7. | Ms. Julie D. Dewey | Chief Corp. Communications & Investor Relations Officer | 1961 |
8. | Mr. Michael Collier Carter | VP of Global Sales | 1972 |
9. | Mr. Jon R. Shear | VP of Corp. Devel. | NA |
10. | Meredith Vornholt | VP of Global Marketing | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
ABT
Abbott Laboratories |
-0.030 0.028% | 106.645 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
SYK
Stryker Corporation |
+0.300 0.089% | 335.84 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
MDT
Medtronic PLC |
-1.130 1.406% | 80.04 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
BSX
Boston Scientific Corp |
+0.350 0.480% | 73.13 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | 4.264M | -130.826M | -82.197M | -102.087M | -48.437M |
Minority Interest | - | - | - | - | - |
Net Income | 3.001M | -131.36M | -83.065M | -103.686M | -49.205M |
Selling General Administrative | 322.138M | 309.311M | 267.154M | 305.812M | 266.608M |
Gross Profit | 276.367M | 266.042M | 249.902M | 268.35M | 273.324M |
Reconciled Depreciation | 10.327M | 8.678M | 8.186M | 7.8M | 3.887M |
Ebit | -98.836M | -90.934M | -71.038M | -104.279M | -45.63M |
Ebitda | -203.836M | -70.934M | -62.852M | -96.479M | -41.743M |
Depreciation And Amortization | -105M | 20M | 8.186M | 7.8M | 3.887M |
Operating Income | -98.836M | -90.934M | -62.852M | -96.479M | -41.743M |
Other Operating Expenses | 505.201M | 477.839M | 424.9M | 486.734M | 429.032M |
Interest Expense | 6.432M | 19.749M | 21.806M | 10.931M | 10.401M |
Tax Provision | 1.263M | 0.534M | 0.868M | 1.599M | 0.768M |
Interest Income | 4.021M | 0.671M | 2.956M | 6.02M | 4.871M |
Net Interest Income | -2.411M | -19.078M | -18.85M | -4.911M | -5.53M |
Income Tax Expense | 1.263M | 0.534M | 0.868M | 1.599M | 0.768M |
Total Revenue | 406.365M | 386.905M | 362.048M | 390.255M | 387.289M |
Total Operating Expenses | 375.203M | 356.976M | 312.754M | 364.829M | 315.067M |
Cost Of Revenue | 129.998M | 120.863M | 112.146M | 121.905M | 113.965M |
Total Other Income Expense Net | 103.1M | -39.892M | -19.345M | -5.608M | -1.164M |
Net Income From Continuing Ops | 3.001M | -131.36M | -83.065M | -103.686M | -49.205M |
Net Income Applicable To Common Shares | 3.001M | -131.36M | -83.065M | -103.686M | -49.205M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Total Assets | 602.408M | 574.544M | 789.428M | 469.645M | 463.116M |
Intangible Assets | - | - | - | - | - |
Other Current Assets | 9.984M | 5.185M | 4.173M | 9.838M | 6.621M |
Total Liab | 278.532M | 270.928M | 400.968M | 253.293M | 217.633M |
Total Stockholder Equity | 323.876M | 303.616M | 388.46M | 216.352M | 245.483M |
Other Current Liab | 52.363M | 50.204M | 3.975M | 54.563M | 38.909M |
Common Stock | 0.035M | 0.035M | 0.035M | 0.032M | 0.03M |
Capital Stock | 0.035M | 0.035M | 0.035M | 0.032M | 0.03M |
Retained Earnings | -607.197M | -624.193M | -492.833M | -409.768M | -306.082M |
Good Will | - | - | - | - | - |
Other Assets | 3.77M | 5.099M | 22.791M | 14.294M | 6.456M |
Cash | 120.373M | 34.71M | 44.597M | 65.373M | 51.266M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 79.212M | 82.203M | 239.165M | 70.611M | 62.414M |
Current Deferred Revenue | - | - | 43.305M | - | - |
Net Debt | 76.79M | 132.002M | 282.639M | 115.372M | 101.128M |
Short Term Debt | - | - | 168.776M | - | - |
Short Long Term Debt | - | - | 168.776M | - | - |
Short Long Term Debt Total | 197.163M | 166.712M | 327.236M | 180.745M | 152.394M |
Other Stockholder Equity | 934.132M | 928.138M | 880.66M | 626.401M | 552.535M |
Property Plant Equipment | 22.271M | 20.664M | 13.531M | 11.766M | 12.801M |
Total Current Assets | 562.937M | 531.204M | 753.106M | 422.052M | 443.859M |
Long Term Investments | - | - | - | - | - |
Short Term Investments | 254.012M | 327.317M | 543.373M | 172.429M | 213.281M |
Net Receivables | 78.93M | 70.475M | 77.667M | 82.833M | 80.656M |
Long Term Debt | 186.867M | 151.31M | 141.771M | 160.3M | 152.394M |
Inventory | 99.638M | 93.517M | 83.296M | 91.579M | 92.035M |
Accounts Payable | 26.849M | 31.999M | 23.109M | 16.048M | 23.505M |
Accumulated Other Comprehensive Income | -3.094M | -0.364M | 0.598M | -0.313M | -1.077M |
Non Currrent Assets Other | 3.77M | 5.099M | 4.649M | 14.294M | 6.456M |
Non Current Assets Total | 39.471M | 43.34M | 36.322M | 47.593M | 19.257M |
Capital Lease Obligations | 10.296M | 15.402M | 16.689M | 20.445M | - |
Long Term Debt Total | 186.867M | 151.31M | 141.771M | 160.3M | 152.394M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | 71.832M | 214.055M | -371.343M | 43.302M | 14.65M |
Total Cashflows From Investing Activities | 64.29M | 201.715M | -369.868M | 32.33M | 6.433M |
Total Cash From Financing Activities | -2.457M | -169.381M | 346.905M | 32.093M | 7.754M |
Net Income | 3.001M | -131.36M | -83.065M | -103.686M | -49.205M |
Change In Cash | 85.663M | -9.887M | -21.126M | 14.457M | 8.221M |
Begin Period Cash Flow | 35.316M | 45.203M | 66.329M | 51.872M | 43.651M |
End Period Cash Flow | 120.979M | 35.316M | 45.203M | 66.329M | 51.872M |
Total Cash From Operating Activities | 24.675M | -41.881M | 1.191M | -50.225M | -5.708M |
Depreciation | 10.327M | 8.678M | 8.186M | 7.8M | 3.887M |
Other Cashflows From Investing Activities | - | - | 7.5M | -7.5M | -7.5M |
Dividends Paid | - | - | - | - | - |
Change To Inventory | -7.828M | -17.225M | 2.523M | -0.938M | 3.846M |
Sale Purchase Of Stock | 6.393M | 11.181M | 224.214M | 35.15M | 9.496M |
Other Cashflows From Financing Activities | -2.457M | -8.062M | 199.761M | -3.057M | -1.742M |
Capital Expenditures | 7.542M | 12.34M | 6.025M | 3.472M | 8.217M |
Change In Working Capital | -48.89M | 15.849M | 10.79M | -2.89M | -5.844M |
Other Non Cash Items | 3.439M | 13.263M | 14.946M | 7.912M | 7.382M |
Free Cash Flow | 17.133M | -54.221M | -4.834M | -53.697M | -13.925M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Vanguard Explorer Inv | 6 months ago | 1266550 |
2. | Vanguard Total Stock Mkt Idx Inv | 4 months ago | 1073584 |
3. | Select Medical Tech and Devcs | 5 months ago | 1000000 |
4. | Invesco Global Multi Cap Growth | 6 months ago | 1000000 |
5. | Invesco Global Opportunities A | 5 months ago | 895431 |
6. | Vanguard Small Cap Index | 4 months ago | 884540 |
7. | iShares Russell 2000 ETF | 4 months ago | 855555 |
8. | Vanguard Institutional Extnd Mkt Idx Tr | 4 months ago | 513575 |
9. | Vanguard Small Cap Growth Index Inv | 4 months ago | 495827 |
10. | Meridian Growth Legacy | 6 months ago | 437331 |
11. | CS (Lux) Digital Health Equity SB USD | 5 months ago | 360000 |
12. | Fidelity® Small Cap Index | 6 months ago | 332861 |
13. | Alger Weatherbie Specialized Growth A | 6 months ago | 328195 |
14. | Vanguard Strategic Equity Inv | 6 months ago | 296669 |
15. | Vanguard VIF Small Co Gr | 6 months ago | 275073 |
16. | SPDR® S&P Health Care Equipment ETF | 4 months ago | 266663 |
17. | iShares US Medical Devices ETF | 4 months ago | 240062 |
18. | iShares Russell 2000 Value ETF | 4 months ago | 216138 |
19. | Strategic Advisers® Small-Mid Cap | 6 months ago | 210233 |
20. | Bellevue (Lux) Bellevue Dgtl Hthl I2 EUR | 4 months ago | 197324 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Vanguard Group Inc | 6 months ago | 4231905 |
2. | Armistice Capital, LLC | 6 months ago | 3456000 |
3. | BlackRock Inc | 6 months ago | 3129906 |
4. | ArrowMark Colorado Holdings, LLC (ArrowMark Partners) | 6 months ago | 2468110 |
5. | BRAIDWELL LP | 6 months ago | 1776368 |
6. | Rock Springs Capital Management LP | 6 months ago | 1211600 |
7. | D. E. Shaw & Co LP | 6 months ago | 1133149 |
8. | FMR Inc | 6 months ago | 1084625 |
9. | Fred Alger Management, LLC | 6 months ago | 1053812 |
10. | Amvescap Plc. | 6 months ago | 1048098 |
11. | State Street Corporation | 6 months ago | 1046933 |
12. | Balyasny Asset Management LLC | 6 months ago | 936347 |
13. | UBS Group AG | 6 months ago | 903272 |
14. | Geode Capital Management, LLC | 6 months ago | 729574 |
15. | Principal Financial Group Inc | 6 months ago | 717443 |
16. | Goldman Sachs Group Inc | 6 months ago | 616890 |
17. | Millennium Management LLC | 6 months ago | 615418 |
18. | Two Sigma Advisers, LLC | 6 months ago | 525100 |
19. | Two Sigma Investments LLC | 6 months ago | 506750 |
20. | Assenagon Asset Management SA | 6 months ago | 427742 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).